Volume 9, Issue 4 (2018, Volume 9, Number 4 2019)                   jdc 2019, 9(4): 288-301 | Back to browse issues page

XML Persian Abstract Print


1- Student Researches Committee, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Department of Pharmaceutical Education, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran , shahlamirzaeei@gmail.com
Abstract:   (1362 Views)
Fungi are eukaryotic organisms that potentially have the ability to cause disease in humans and animals. Fungal infections are called mycosis, which are divided into four types of superficial, cutaneous, subcutaneous and systemic, depending on the area of ​​the body involved. Though cutaneous mycoses are rarely life-threatening infections, they can isolate the patient socially due to the disfigurement of the tissues they caused, as a result of which, treatment has always been an important issue. On the other hand the similarity of fungi to mammalian cells led to difficulties in the development of novel antifungal drugs. Consequently, in recent years, extensive efforts have been made to design and develop novel drug delivery systems with better efficacy for drug delivery of conventional anti-fungal drugs. In this study, we compared conventional forms and novel drug delivery systems of a number of antifungal drugs. All studies confirm the relative priority of novel drug delivery systems to conventional forms in terms of penetration, release, and antifungal effects.
Full-Text [PDF 640 kb]   (1116 Downloads)    
Type of Study: Review | Subject: Special
Received: 2019/03/12 | Accepted: 2019/03/12 | Published: 2019/03/12